Michael J. Goldstein, MD, FACS
Renowned transplant surgeon appointed Associate Professor of Surgery and Director of Kidney and Pancreas Transplantation at the Mount Sinai Medical Center
Michael J. Goldstein, MD, FACS, a renowned transplant surgeon, who specializes in high-risk procedures that improves patient acess to transplantation, has been appointed Associate Professor of Surgery and Director of Kidney and Pancreas Transplantation at The Mount Sinai Medical Center. One of Dr. Goldstein’s areas of expertise is operating on patients with high immunologic risk, and helping them to overcome organ rejection through the use of advanced immunosuppressant drug regimens. He also performs procedures that maximize the use of organs that might otherwise have been less than optimal for transplantation. His innovative technique for minimally invasive kidney transplantation utilizing an astoundingly small two-inch incision minimizes pain, accelerates patient recovery, and reduces hospital stay.
"My goal as a surgeon and a clinician is to provide more patients with access to safe transplantation," says Dr. Goldstein. "I've been working to do that through better utilization of organs from deceased and living donors."
Dr. Goldstein says he is looking forward to working closely with Mount Sinai's Living Donor Program. "Recipients of organs from living donors have much better outcomes than those who receive organs from deceased donors," he says. "Mount Sinai is unique in the work it has done to increase the number of transplants coming from living donors, through outreach and through the efforts of the Center for Living Donation."
In addition to his work at Mount Sinai, Dr. Goldstein is Medical Director of the New York Organ Donor Network, a non-profit organization that works to improve the quality and the number of organs available for transplant in the Greater New York area. He also serves as Vice Chair of the United Network for Organ Sharing's Organ Availability Committee, and is on the Medical Directors Council of the Association of Organ Procurement Organizations.
Dr. Goldstein says Mount Sinai is on course to become one of the leading transplantation programs in the nation, in clinical practice, and in research. "Transplantation and immunology go hand in hand," he says. "You can’t have transplants without immunosuppression, and the study of ways to prevent organ rejection is critical to the whole process."
Prior to joining Mount Sinai, Dr. Goldstein was an Assistant Attending Surgeon and an Assistant Professor at New York Presbyterian Hospital, Columbia University Medical Center.